Overexpression of HDAC1 induces cellular senescence by Sp1/PP2A/pRb pathway

Biochemical and Biophysical Research Communications

Volumn 407, Issue 3, 2011, Pages 587-592

  Chuang, Jian Ying ^a   Hung, Jan Jong ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

HDAC1; PP2A; PRb; Senescence; Sp1

Indexed keywords

HISTONE DEACETYLASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN P300; RETINOBLASTOMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; DEACETYLATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SENESCENCE; TUMOR CELL; UTERINE CERVIX CANCER;

ANIMALS; CELL AGING; FEMALE; HELA CELLS; HISTONE DEACETYLASE 1; HUMANS; MICE; MICE, SCID; PROMOTER REGIONS, GENETIC; PROTEIN PHOSPHATASE 2; RETINOBLASTOMA PROTEIN; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; UTERINE CERVICAL NEOPLASMS;

EID: 79954602868     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.03.068     Document Type: Article

References (36)

1. Hagelstrom R.T., Blagoev K.B., Niedernhofer L.J., Goodwin E.H., Bailey S.M. Hyper telomere recombination accelerates replicative senescence and may promote premature aging. Proc. Natl. Acad. Sci. USA 2010, 107:15768-15773.
2. Bandyopadhyay D., Curry J.L., Lin Q., Richards H.W., Chen D., Hornsby P.J., Timchenko N.A., Medrano E.E. Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi. Aging Cell 2007, 6:577-591.
3. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 2001, 11:S27-S31.
4. Mathon N.F., Lloyd A.C. Cell senescence and cancer. Nat. Rev. Cancer 2001, 1:203-213.
5. Coleman P.R., Hahn C.N., Grimshaw M., Lu Y., Li X., Brautigan P.J., Beck K., Stocker R., Vadas M.A., Gamble J.R. Stress-induced premature senescence mediated by a novel gene, SENEX, results in an anti-inflammatory phenotype in endothelial cells. Blood 2010, 116:4016-4024.
6. Ramirez R.D., Herbert B.S., Vaughan M.B., Zou Y., Gandia K., Morales C.P., Wright W.E., Shay J.W. Bypass of telomere-dependent replicative senescence (M1) upon overexpression of CDK4 in normal human epithelial cells. Oncogene 2003, 22:433-444.
7. Chicas A., Wang X., Zhang C., McCurrach M., Zhao Z., Mert O., Dickins R.A., Narita M., Zhang M., Lowe S.W. Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell 2010, 17:376-387.
8. Kuilman T., Michaloglou C., Mooi W.J., Peeper D.S. The essence of senescence. Genes Dev. 2010, 24:2463-2479.
9. Hume A.J., Finkel J.S., Kamil J.P., Coen D.M., Culbertson M.R., Kalejta R.F. Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 2008, 320:797-799.
10. Bockstaele L., Bisteau X., Paternot S., Roger P.P. Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation. Mol. Cell. Biol. 2009, 29:4188-4200.
11. Gao D., Inuzuka H., Korenjak M., Tseng A., Wu T., Wan L., Kirschner M., Dyson N., Wei W. Cdh1 regulates cell cycle through modulating the claspin/Chk1 and the Rb/E2F1 pathways. Mol. Biol. Cell 2009, 20:3305-3316.
12. Deng Q., Li Y., Tedesco D., Liao R., Fuhrmann G., Sun P. The ability of E1A to rescue Ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins. Cancer Res. 2005, 65:8298-8307.
13. Takahashi A., Ohtani N., Hara E. Irreversibility of cellular senescence: dual roles of p16INK4a/Rb-pathway in cell cycle control. Cell Div. 2007, 2:10.
14. Alberts A.S., Thorburn A.M., Shenolikar S., Mumby M.C., Feramisco J.R. Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein by protein phosphatases. Proc. Natl. Acad. Sci. USA 1993, 90:388-392.
15. Feschenko M.S., Stevenson E., Nairn A.C., Sweadner K.J. A novel cAMP-stimulated pathway in protein phosphatase 2A activation. J. Pharmacol. Exp. Ther. 2002, 302:111-118.
16. Bandyopadhyay D., Medrano E.E. The emerging role of epigenetics in cellular and organismal aging. Exp. Gerontol. 2003, 38:1299-1307.
17. Soliman M.A., Berardi P., Pastyryeva S., Bonnefin P., Feng X., Colina A., Young D., Riabowol K. ING1a expression increases during replicative senescence and induces a senescent phenotype. Aging Cell 2008, 7:783-794.
18. Willis-Martinez D., Richards H.W., Timchenko N.A., Medrano E.E. Role of HDAC1 in senescence, aging, and cancer. Exp. Gerontol. 2010, 45:279-285.
19. Hung J.J., Wang Y.T., Chang W.C. Sp1 deacetylation induced by phorbol ester recruits p300 to activate 12(S)-lipoxygenase gene transcription. Mol. Cell. Biol. 2006, 26:1770-1785.
20. Chuang J.Y., Wang Y.T., Yeh S.H., Liu Y.W., Chang W.C., Hung J.J. Phosphorylation by c-Jun NH2-terminal kinase 1 regulates the stability of transcription factor Sp1 during mitosis. Mol. Biol. Cell 2008, 19:1139-1151.
21. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120:513-522.
22. Jarrard D.F., Sarkar S., Shi Y., Yeager T.R., Magrane G., Kinoshita H., Nassif N., Meisner L., Newton M.A., Waldman F.M., Reznikoff C.A. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Cancer Res. 1999, 59:2957-2964.
23. Sunahori K., Juang Y.T., Tsokos G.C. Methylation status of CpG islands flanking a cAMP response element motif on the protein phosphatase 2Ac alpha promoter determines CREB binding and activity. J. Immunol. 2009, 182:1500-1508.
24. Goding C.R. Melanoma senescence: HDAC1 in focus. Pigment Cell Res. 2007, 20:336-338.
25. Wang G.L., Salisbury E., Shi X., Timchenko L., Medrano E.E., Timchenko N.A. HDAC1 cooperates with C/EBPalpha in the inhibition of liver proliferation in old mice. J. Biol. Chem. 2008, 283:26169-26178.
26. Iakova P., Awad S.S., Timchenko N.A. Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest. Cell 2003, 113:495-506.
27. Di Marcotullio L., Canettieri G., Infante P., Greco A., Gulino A. Protected from the inside: endogenous histone deacetylase inhibitors and the road to cancer. Biochim. Biophys. Acta 2011, 1815:241-252.
28. Oh Y.M., Kwon Y.E., Kim J.M., Bae S.J., Lee B.K., Yoo S.J., Chung C.H., Deshaies R.J., Seol J.H. Chfr is linked to tumour metastasis through the downregulation of HDAC1. Nat. Cell Biol. 2009, 11:295-302.
29. Wierstra I. Sp1: emerging roles - beyond constitutive activation of TATA-less housekeeping genes. Biochem. Biophys. Res. Commun. 2008, 372:1-13.
30. Papineni S., Chintharlapalli S., Abdelrahim M., Lee S.O., Burghardt R., Abudayyeh A., Baker C., Herrera L., Safe S. Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met. Carcinogenesis 2009, 30:1193-1201.
31. Deniaud E., Baguet J., Mathieu A.L., Pages G., Marvel J., Leverrier Y. Overexpression of Sp1 transcription factor induces apoptosis. Oncogene 2006, 25:7096-7105.
32. Chuang J.Y., Wu C.H., Lai M.D., Chang W.C., Hung J.J. Overexpression of Sp1 leads to p53-dependent apoptosis in cancer cells. Int. J. Cancer 2009, 125:2066-2076.
33. Braig M., Schmitt C.A. Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res. 2006, 66:2881-2884.
34. Kuilman T., Michaloglou C., Vredeveld L.C., Douma S., van Doorn R., Desmet C.J., Aarden L.A., Mooi W.J., Peeper D.S. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008, 133:1019-1031.
35. Roth J.A. Adenovirus p53 gene therapy. Expert Opin. Biol. Ther. 2006, 6:55-61.
36. Fujiwara T., Kataoka M., Tanaka N. Adenovirus-mediated p53 gene therapy for human cancer. Mol. Urol. 2000, 4:51-54.